UK Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012 : Market Research Report

UK Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Published: Sep. 30, 2008 - 156 Pages

1 Table of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 What Is This Report About?; 2.2 Definitions
3 Healthcare Sector Review: 3.1 Healthcare Sector Review; 3.2 Healthcare Expenditure; 3.3 Healthcare Infrastructure; 3.4 Healthcare Policy
4 Drug Delivery Devices in United Kingdom: 4.1 Drug Delivery Devices Overall Revenues (2000-2012); 4.2 Drug Delivery Devices Overall Volume (2000-2012); 4.3 Drug Delivery Devices Company Shares (2005-2006)
5 Inhalation Systems in United Kingdom: 5.1 Inhalation Systems Overall Revenues (2000-2012); 5.2 Inhalation Systems Overall Volume (2000-2012); 5.3 Inhalation Systems Average Price (2000-2012); 5.4 Inhalation Systems Distribution Share (2005-2006); 5.5 Inhalation Systems Company Share (2005-2006)
6 Infusion Systems in United Kingdom: 6.1 Infusion Systems Overall Revenues (2000-2012); 6.2 Infusion Systems Overall Volume (2000-2012); 6.3 Infusion Systems Average Price (2000-2012); 6.4 Infusion Systems Distribution Share (2005-2006); 6.5 Infusion Systems Company Share (2005-2006)
7 Needle Free Injections in United Kingdom: 7.1 Needle Free Injections Overall Revenue (2000-2012); 7.2 Needle Free Injections Overall Volume (2000-2012); 7.3 Needle Free Injections Average Price (2000-2012); 7.4 Needle Free Injections Distribution Share (2005-2006); 7.5 Needle Free Injections Company Share (2005-2006)
8 AstraZeneca PLC Company Profile: 8.1 Company Overview; 8.2 Business Overview; 8.3 Locations And Subsidiaries
9 3M Company Profile: 9.1 Company Overview; 9.2 Business Overview; 9.3 Value Chain Analysis; 9.4 SWOT Analysis; 9.5 Revenue Analysis; 9.6 Financial and Operational Review; 9.7 Locations And Subsidiaries
10 Baxter International Company Profile: 10.1 Company Overview; 10.2 Business Overview; 10.3 Value Chain Analysis; 10.4 SWOT Analysis; 10.5 Revenue Analysis; 10.6 Financial and Operational Review; 10.7 Locations And Subsidiaries; 10.8 Baxter International Inc. Pipeline Products
11 GlaxoSmithKline plc Company Profile: 11.1 Company Overview; 11.2 Business Overview; 11.3 Locations And Subsidiaries
12 Novartis AG Company Profile: 12.1 Company Overview; 12.2 Business Overview; 12.3 Locations And Subsidiaries
13 Regulation System: 13.1 Medical Equipment Approval Process; 13.2 Medical Device approval fee; 13.3 Post Market Surveillance (PMS)
14 Pricing and Reimbursement: 14.1 Market Pricing; 14.2 Government Policies for Reimbursement
15 Distribution Structure
16 Financial Deals Landscape: 16.1 Acquisition
17 Recent Developments: 17.1 Strategy And Business Planning; 17.2 Corporate Communications
18 Appendix: 18.1 Global Markets Direct Research Methodology; 18.2 Coverage; 18.3 Secondary Research; 18.4 Primary Research; 18.5 Models; 18.6 Forecasts; 18.7 Expert Panels; 18.8 Currency Conversion; 18.9 Contact Us; 18.10 Disclaimer
1.1 List of Tables: Table 1: Number of Doctor by Specialty in UK, 2003 - 2007; Table 2: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012; Table 3: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Table 4: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Table 5: Drug Delivery Devices, United Kingdom, Category Revenues ($ mn), 2000-2012; Table 6: Drug Delivery Devices, United Kingdom, Category Revenues ($ mn), Historic, 2000-2007; Table 7: Drug Delivery Devices, United Kingdom, Category Revenues ($ mn), Forecast, 2007-2012; Table 8: Drug Delivery Devices, United Kingdom, Category Volume (Units), 2000-2012; Table 9: Drug Delivery Devices, United Kingdom, Category Volume (Units), Historic, 2000-2007; Table 10: Drug Delivery Devices, United Kingdom, Category Volume (Units), Forecast, 2007-2012; Table 11: Drug Delivery Devices, United Kingdom, Company Share by Revenue ($ mn), 2005-2006; Table 12: Inhalation Systems, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Table 13: Inhalation Systems, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Table 14: Inhalation Systems, United Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007; Table 15: Inhalation Systems, United Kingdom, Revenue by Segment ($ mn), Forecast, 2007-2012; Table 16: Metered Dose Inhaler Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Table 17: Metered Dose Inhaler Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Table 18: Dry Powder Inhaler Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Table 19: Dry Powder Inhaler Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Table 20: Inhalation Systems, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Table 21: Inhalation Systems, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Table 22: Metered Dose Inhaler Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Table 23: Metered Dose Inhaler Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Table 24: Dry Powder Inhaler Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Table 25: Dry Powder Inhaler Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Table 26: Metered Dose Inhaler Devices, United Kingdom, Average Price ($), Historic, 2000-2007; Table 27: Metered Dose Inhaler Devices, United Kingdom, Average Price ($), Forecast, 2007-2012; Table 28: Dry Powder Inhaler Devices, United Kingdom, Average Price ($), Historic, 2000-2007; Table 29: Dry Powder Inhaler Devices, United Kingdom, Average Price ($), Forecast, 2007-2012; Table 30: Inhalation Systems, United Kingdom, Distribution Share by Revenue ($ mn), 2005-2006; Table 31: Inhalation Systems, United Kingdom, Company Share by Revenue ($ mn), 2005-2006; Table 32: Infusion Systems, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Table 33: Infusion Systems, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Table 34: Infusion Systems, United Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007; Table 35: Infusion Systems, United Kingdom, Revenue by Segment ($ mn), Forecast, 2007-2012; Table 36: Infusion Disposable Sets, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Table 37: Infusion Disposable Sets, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Table 38: Infusion Pumps, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Table 39: Infusion Pumps, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Table 40: Syringe Pumps, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Table 41: Syringe Pumps, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Table 42: Infusion Systems, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Table 43: Infusion Systems, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Table 44: Infusion Disposable Sets, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Table 45: Infusion Disposable Sets, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Table 46: Infusion Pumps, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Table 47: Infusion Pumps, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Table 48: Syringe Pumps, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Table 49: Syringe Pumps, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Table 50: Infusion Pumps, United Kingdom, Average Price ($), Historic, 2000-2007; Table 51: Infusion Pumps, United Kingdom, Average Price ($), Forecast, 2007-2012; Table 52: Syringe Pumps, United Kingdom, Average Price ($), Historic, 2000-2007; Table 53: Syringe Pumps, United Kingdom, Average Price ($), Forecast, 2007-2012; Table 54: Infusion Disposable Sets, United Kingdom, Average Price ($), Historic, 2000-2007; Table 55: Infusion Disposable Sets, United Kingdom, Average Price ($), Historic, 2000-2007; Table 56: Infusion Systems, United Kingdom, Distribution Share by Revenue ($ mn), 2005-2006; Table 57: Infusion Systems, United Kingdom, Company Share by Revenue ($ mn), 2005-2006; Table 58: Needle Free Injections, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Table 59: Needle Free Injections, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Table 60: Needle Free Injections, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Table 61: Needle Free Injections, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Table 62: Needle Free Injections, United Kingdom, Average Price ($), Historic, 2000-2007; Table 63: Needle Free Injections, United Kingdom, Average Price ($), Forecast, 2007-2012; Table 64: Needle Free Injections, United Kingdom, Distribution Share by Revenue ($ mn), 2005-2006; Table 65: Needle Free Injections, United Kingdom, Company Share by Revenue ($ mn), 2005-2006; Table 66: AstraZeneca PLC, Subsidiaries; Table 67: AstraZeneca PLC, Subsidiaries(Contd..); Table 68: 3M Company, SWOT Analysis, 2006; Table 69: 3M Company, Revenue by Segment, USD Million, 2003-2007; Table 70: 3M Company, Revenue by Geography, USD Million, 2003-2007; Table 71: 3M Company, Financial Statements, USD Million, 2003-2007; Table 72: 3M Company, Financial Ratios, USD Million, 2003-2007; Table 73: 3M Company, Subsidiaries; Table 74: Baxter International Inc., SWOT Analysis, 2006; Table 75: Baxter International Inc., Revenue by Segment, USD Million, 2003-2007; Table 76: Baxter International Inc., Revenue by Geography, USD Million, 2003-2007; Table 77: Baxter International Inc., Financial Statements, USD Million, 2003-2007; Table 78: Baxter International Inc., Financial Ratios, USD Million, 2003-2007; Table 79: Baxter International Inc., Other Locations; Table 80: Baxter International Inc., Subsidiaries; Table 81: GlaxoSmithKline plc, Subsidiaries; Table 82: Novartis Medical Nutrition, Other Locations; Table 83: Novartis Medical Nutrition, Other Locations(Contd..); Table 84: Medical Device Approval Fee in UK, 2006; Table 85: Currency Conversion from USD to Local Currency at 2007 Constant Rate 1
1.2 List of Figures: Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006; Figure 2: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012; Figure 3: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Figure 4: Drug Delivery Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 5: Drug Delivery Devices, United Kingdom, Category Revenues ($ mn), 2000-2012; Figure 6: Drug Delivery Devices, United Kingdom, Category Revenues ($ mn), Historic, 2000-2007; Figure 7: Drug Delivery Devices, United Kingdom, Category Revenues ($ mn), Forecast, 2007-2012; Figure 8: Drug Delivery Devices, United Kingdom, Category Volume (Units), 2000-2012; Figure 9: Drug Delivery Devices, United Kingdom, Category Volume (Units), Historic, 2000-2007; Figure 10: Drug Delivery Devices, United Kingdom, Category Volume (Units), Forecast, 2007-2012; Figure 11: Drug Delivery Devices, United Kingdom, Company Share (%), 2006; Figure 12: Inhalation Systems, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Figure 13: Inhalation Systems, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 14: Inhalation Systems, United Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007; Figure 15: Inhalation Systems, United Kingdom, Revenue by Segment ($ mn), Forecast, 2007-2012; Figure 16: Metered Dose Inhaler Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Figure 17: Metered Dose Inhaler Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 18: Dry Powder Inhaler Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Figure 19: Dry Powder Inhaler Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 20: Inhalation Systems, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Figure 21: Inhalation Systems, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Figure 22: Metered Dose Inhaler Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Figure 23: Metered Dose Inhaler Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Figure 24: Dry Powder Inhaler Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Figure 25: Dry Powder Inhaler Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Figure 26: Metered Dose Inhaler Devices, United Kingdom, Average Price ($), Historic, 2000-2007; Figure 27: Metered Dose Inhaler Devices, United Kingdom, Average Price ($), Forecast, 2007-2012; Figure 28: Dry Powder Inhaler Devices, United Kingdom, Average Price ($), Historic, 2000-2007; Figure 29: Dry Powder Inhaler Devices, United Kingdom, Average Price ($), Forecast, 2007-2012; Figure 30: Inhalation Systems, United Kingdom, Distribution Share (%), 2006; Figure 31: Inhalation Systems, United Kingdom, Company Share (%), 2006; Figure 32: Infusion Systems, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Figure 33: Infusion Systems, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 34: Infusion Systems, United Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007; Figure 35: Infusion Systems, United Kingdom, Revenue by Segment ($ mn), Forecast, 2007-2012; Figure 36: Infusion Disposable Sets, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Figure 37: Infusion Disposable Sets, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 38: Infusion Pumps, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Figure 39: Infusion Pumps, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 40: Syringe Pumps, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Figure 41: Syringe Pumps, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 42: Infusion Disposable Sets, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Figure 43: Infusion Disposable Sets, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Figure 44: Infusion Pumps, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Figure 45: Infusion Pumps, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Figure 46: Syringe Pumps, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Figure 47: Syringe Pumps, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Figure 48: Infusion Pumps, United Kingdom, Average Price ($), Historic, 2000-2007; Figure 49: Infusion Pumps, United Kingdom, Average Price ($), Forecast, 2007-2012; Figure 50: Syringe Pumps, United Kingdom, Average Price ($), Historic, 2000-2007; Figure 51: Syringe Pumps, United Kingdom, Average Price ($), Forecast, 2007-2012; Figure 52: Infusion Disposable Sets, United Kingdom, Average Price ($), Historic, 2000-2007; Figure 53: Infusion Disposable Sets, United Kingdom, Average Price ($), Forecast, 2007-2012; Figure 54: Infusion Systems, United Kingdom, Distribution Share (%), 2006; Figure 55: Infusion Systems, United Kingdom, Company Share (%), 2006; Figure 56: Needle Free Injections, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007; Figure 57: Needle Free Injections, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 58: Needle Free Injections, United Kingdom, Overall Volume (Units), Historic, 2000-2007; Figure 59: Needle Free Injections, United Kingdom, Overall Volume (Units), Forecast, 2007-2012; Figure 60: Needle Free Injections, United Kingdom, Average Price ($), Historic, 2000-2007; Figure 61: Needle Free Injections, United Kingdom, Average Price ($), Forecast, 2007-2012; Figure 62: Needle Free Injections, United Kingdom, Distribution Share (%), 2006; Figure 63: 3M Company, Value Chain Analysis; Figure 64: Baxter International Inc., Value Chain Analysis; Figure 65: Flowchart for Classification of Non-invasive Devices in UK, 2007; Figure 66: Flowchart for Classification of Invasive Devices in UK, 2007; Figure 67: Flowchart for Classification of Invasive Devices in UK, 2007; Figure 68: Flowchart for Classification of Invasive Devices in UK, 2007; Figure 69: Flowchart for Classification of Invasive Devices in UK, 2007; Figure 70: Flowchart for Classification of Active Devices in UK, 2007; Figure 71: Flowchart for Classification of Active Devices in UK, 2007; Figure 72: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007; Figure 73: Conformity Assessment of Class-I Medical Devices in UK, 2007; Figure 74: Conformity Assessment of Class-IIa Medical Devices in UK, 2007; Figure 75: Conformity Assessment of Class-IIb Medical Devices in UK, 2007; Figure 76: Conformity Assessment of Class-III Medical Devices in UK, 2007; Figure 77: Global Markets Direct Methodology

Abstract

UK Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the UK Drug drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in UK

Scope

The report provides drug delivery devices information broken down into detailed categories and segments in United kingdom.
Total revenues, products sold, end users, and average pricing.
Market shares of all the key competitors.
Key pipeline products that are set to shape the market, broken down by sector.
Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Customer, hospitals and physicians data.

Reasons to buy

Gain a strong understanding of the drug delivery devices market in United Kingdom.
Evaluate and compare the attractiveness of the market in the country.
Identify growth segments and opportunities in each industry sector within the country.
Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
Analyze the competitiveness of the market in the country and identify hotspots.
Develop strategies based on the latest product, brand, expansion and research and development news in the country.
Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

UK Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Table of Contents

Abstract